English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Glaxosmithkline
Carol Ostrow
| Dec 16, 2017
Multiple myeloma study results encouraging, GSK says
Carol Ostrow
| Dec 15, 2017
GSK receives FDA approval for expanded use of Nucala
Carol Ostrow
| Dec 15, 2017
GSK says Shingrix promising for preventing shingles in stem cell transplant patients
Carol Ostrow
| Sep 24, 2017
GlaxoSmithKline, Innoviva COPD therapy gains FDA approval
Carol Ostrow
| Sep 23, 2017
Self-injectable form of Lupus therapy clears hurdle in Europe
Carol Ostrow
| Sep 21, 2017
GSK’s Shingrix shingles vaccine clears an FDA hurdle
Carol Ostrow
| Sep 18, 2017
Salford Lung Study shows promise for GlaxoSmithKline asthma treatment
Nicholas Gueguen
| Aug 1, 2017
ViiV Healthcare drug duo as effective in treating HIV as larger drug combinations
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'
1
2
»
Last »